Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Genome Editing Market, By Technology
7.1. Genome Editing Market, by Technology, 2020-2030
7.1.1. (CRISPR)/Cas9
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. TALENs/MegaTALs
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. ZFN
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Genome Editing Market, By Delivery Method
8.1. Genome Editing Market, by Delivery Method, 2020-2030
8.1.1. Ex-Vivo
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. In-Vivo
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Genome Editing Market, By Application
9.1. Genome Editing Market, by Application, 2020-2030
9.1.1. Cell Line Engineering
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Animal Genetic Engineering
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Plant Genetic Engineering
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Other Applications
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Genome Editing Market, By End-use
10.1. Genome Editing Market, by End-use, 2020-2030
10.1.1. Biotechnology & Pharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Academic & Government Research Institutes
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Contract Research Organizations
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Genome Editing Market, By Component
11.1. Genome Editing Market, by Component, 2020-2030
11.1.1. Contract
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. In-house
11.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Genome Editing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.5. Market Revenue and Forecast, by Component (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.1.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.1.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.1.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.2.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.2.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.2.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.3.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.3.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.3.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.7.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.8.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.8.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.8.5. Market Revenue and Forecast, by Component (2016-2030)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Technology (2016-2030)
12.4.9.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.4.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.9.4. Market Revenue and Forecast, by End-use (2016-2030)
12.4.9.5. Market Revenue and Forecast, by Component (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.5. Market Revenue and Forecast, by Component (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.6.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.6.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.6.5. Market Revenue and Forecast, by Component (2016-2030)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Technology (2016-2030)
12.5.7.2. Market Revenue and Forecast, by Delivery Method (2016-2030)
12.5.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.7.4. Market Revenue and Forecast, by End-use (2016-2030)
12.5.7.5. Market Revenue and Forecast, by Component (2016-2030)
Chapter 13. Company Profiles
13.1. Caribou Biosciences, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Sangamo, Editas Medicine
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Recombinetics, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. CRISPR THERAPEUTICS
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Intellia Therapeutics
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sigma Aldrich Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms